Bioavailability refers to the extent and rate at which the active moiety (drug or metabolite) enters systemic circulation, thereby accessing the site of action. Many nutraceuticals have poor bioavailability due to their large molecular size or poor solubility. Nanotechnology can significantly enhance bioavailability by reducing particle size and improving solubility, thus ensuring that the active compounds are more readily absorbed by the body.
